Frazier Life Sciences VIII is a Venture Capital Fund in Washington, that has raised $262.00 mm from 46 investors, with a minimum investment of $68.75 k, for a fund started in Oct 2015. Data from SEC filing on 28 Oct 2015.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
IRS number
475290848
AUM ?
$372.19 mm
Address
Frazier Life Sciences VIII
601 UNION STREET
SUITE 3200
SEATTLE
WA 98101
601 UNION STREET
SUITE 3200
SEATTLE
WA 98101
Phone
206-254-7200
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Frazier Life Sciences Management, LP | $4.04 bn | |
Frazier Healthcare Vii-a, L.P. | $63.47 mm | Private Equity Fund |
Frazier Healthcare VII, L.P. | $218.28 mm | Private Equity Fund |
Frazier Life Sciences IX, L.P. | $756.28 mm | Venture Capital Fund |
Frazier Life Sciences Public Fund, L.P. | $996.41 mm | Private Equity Fund |
Frazier Life Sciences VIII, L.P. | $372.19 mm | Venture Capital Fund |
Frazier Life Sciences X, L.P. | $642.06 mm | Venture Capital Fund |
Frazier Life Sciences XI, L.P. | $987.24 mm | Venture Capital Fund |
Latest filings (excl ownership)
Latest ownership filings
SC 13D/A
Arcutis Biotherapeutics, Inc.
6 Mar 24
SC 13D/A
ALPINE IMMUNE SCIENCES, INC.
22 Nov 23
SC 13D/A
Arcutis Biotherapeutics, Inc.
26 Oct 23
4
James N Topper
26 Oct 23
4
James N Topper
9 Aug 22
SC 13D/A
Arcutis Biotherapeutics, Inc.
9 Aug 22
4
James N Topper
15 Feb 22
SC 13D/A
ALPINE IMMUNE SCIENCES, INC.
15 Feb 22
SC 13G/A
Sierra Oncology, Inc.
28 Jan 22
SC 13D/A
ALPINE IMMUNE SCIENCES, INC.
21 Sep 21